Gennao Bio

New York, United States

Gennao Bio is a genetic medicines company that develops targeted nucleic acid therapeutics to cure muscle diseases.

Dec 2021

Series A

Top Investors

OrbiMedLogos CapitalSurveyor CapitalCureDuchenne Ventures

19,000+ verified contacts

Emails, phones & LinkedIn profiles

Who are Gennao Bio's investors?

Gennao Bio's investors include OrbiMed, Logos Capital, Surveyor Capital, CureDuchenne Ventures.

Where is Gennao Bio headquartered?

Gennao Bio is headquartered in New York, United States.

What does Gennao Bio do?

Gennao Bio is a genetic medicines company that develops targeted nucleic acid therapeutics to cure muscle diseases.

What stage is Gennao Bio at?

Gennao Bio is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated December 22, 2021.

MLA

"Gennao Bio — Funding & Investors." VCBacked, December 22, 2021, https://www.vcbacked.co/company/gennao-bio. Accessed July 1, 2026.

APA

VCBacked. (2021). Gennao Bio — Funding & Investors. Retrieved July 1, 2026, from https://www.vcbacked.co/company/gennao-bio

Wikipedia (cite web)

{{cite web |title=Gennao Bio — Funding & Investors |url=https://www.vcbacked.co/company/gennao-bio |website=VCBacked |access-date=July 1, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated December 22, 2021.